@article{oai:repo.qst.go.jp:00047119,
 author = {Sugyo, Aya and B, Tsuji Atsushi and Sudo, Hitomi and Okada, Maki and Koizumi, Mitsuru and Satoh, Hirokazu and Kurosawa, Gene and Kurosawa, Yoshikazu and Saga, Tsuneo and 須尭 綾 and 辻 厚至 and 須藤 仁美 and 岡田 真希 and 小泉 満 and 佐賀 恒夫},
 issue = {4},
 journal = {PloS one},
 month = {Apr},
 note = {Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, development of more effective therapy is needed. We previously reported that 89Zr-labeled TSP-A01, an antibody against transferrin receptor (TfR), is highly accumulated in a pancreatic cancer xenograft, but not in major normal organs. In the present study, we evaluated the efficacy of radioimmunotherapy (RIT) with 90Y-TSP-A01 in pancreatic cancer mouse models.},
 pages = {e0123761--e0123761},
 title = {Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.},
 volume = {10},
 year = {2015}
}